Harald F. Stock, Ph.D
Harald Stock serves on the Board of Directors of Immatics and is a member of its Audit and Human Resources Committees. Harald has been President & Chief Executive Officer of Malmö, Sweden based ArjoHuntleigh AB, a leading medical device company offering innovative solutions in acute and long-term care, and Executive Vice President of Getinge Group’s (OMX: GETI B) Extended Care Business Area since January 1, 2014. Before joining ArjoHuntleigh and Getinge Group he was the Chief Executive Officer of Grünenthal, a privately held, international research-based pharmaceutical company, headquartered in Germany. Prior to joining Grünenthal in 2009, he was Chairman and Managing Director at DePuy, the Orthopedics Division of Johnson & Johnson. Previously, he held various positions of increasing responsibilities in local and global functions and corporate divisions of the Roche Group until 2005, when he was appointed Senior Vice President of the Global Near Patient Testing business based in Graz, Austria.
He served as a Board Member at the European Federation of Pharmaceutical Industries and Associations (efpia) and is a director at OvaScience, Inc. (NASDAQ: OVAS). He also previously served as Vice-Chairman of the Supervisory Board of PAION AG, was Board Observer of ConforMIS, Inc. and represented Johnson & Johnson on the Board of BVMed, the German Medical Technology Industry Association.
Harald Stock holds a Ph.D. in Inorganic Chemistry from Ruprecht-Karls-University of Heidelberg, Germany.